NCT03738631

Completed

Cardiac Biomarkers After Marathon Running and Coronary Ather...

University of Turku Source

Compare

Other study identifiers

Sponsor study identifier

T171/2018

Study Type

observational

Actual enrollment (reported)

43

Locations

1 country

Sites

1

Timeline

Study Start

August 17, 2018

Actual (reported)

Primary Completion

December 1, 2022

Actual (reported)

Study Completion

December 1, 2022

Actual (reported)

Brief Summary

This study evaluates cardiac biomarkers and their association to coronary artery disease in marathon runners.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 43 participants
Study completion date: December 1, 2022
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
August 17, 2018
Actual (reported)
First Submitted
September 21, 2018
Actual (reported)
First Posted
November 13, 2018
Actual (reported)
Primary Completion
December 1, 2022
Actual (reported)
Study Completion
December 1, 2022
Actual (reported)

Last Updated: May 8, 2024
Status Verified: May 2024
Last Update Submitted: May 7, 2024

Conditions

Coronary Artery Disease

Outcome Measures

Primary Outcomes (2)

Cardiac Troponin-T level after marathon
Cardiac troponin-T levels (ng/L), \[electrochemiluminescence (ECLIA) method\]
0-30minutes after finishing the Paavo Nurmi Marathon
Association Cardiac troponin-T level and coronary CT findings
Cardiac troponin-T levels (ng/L), \[electrochemiluminescence (ECLIA) method\]
Cardiac Troponin-T 0-30 minutes after finishing the Paavo Nurmi Marathon. Control Troponin-T levels and coronary CT angiography at control visit (>30days after marathon).

Study Arms (2)

Under 35 years

Over 44 years

Eligibility Criteria

Age35 Years - 90 Years

Sexmale

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Male participants of the Paavo Nurmi Marathon 2018

You may qualify if:

Age under 35 years or over 44 years

Sponsors & Collaborators

University of Turku
Otherlead

Study Sites (1)

Turku University Hospital, Heart Center

Turku, Finland

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Enrollment

43 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Professor

Study Record Dates

First Submitted

September 21, 2018

First Posted

November 13, 2018

Study Start

August 17, 2018

Actual (reported)

NCT04102787

The Effect of Cardiac Educational Program on Level of Knowledge and Satisfaction Among Coronary Artery Disease Patients in North of Jordan

Not ApplicableUnknown

NCT03265041

Long Term Predictors of Graft Patency After Coronary Artery Bypass Graft Surgery (Multi-slice CT Coronary Angiography Study Validated by Coronary Angiography)

Completed

NCT03731936

Artificial Intelligence to Assess the Association Between Facial Characteristics and Coronary Artery Diseases

Completed

NCT02855905

Year-round Health Enhancing Exercise and Coronary Artery Disease

Not ApplicableCompleted

NCT04342455

A Low-dose Radiation and Contrast Agent Exposure Protocol for Coronary CTA in Diabetic Patients

Not ApplicableUnknown

NCT03538886

Nordic-Baltic Coronary Revascularization Study in Patients With Proximal Left Descending Coronary Artery (LAD) Lesion.

Not ApplicableTerminated

Participant of Paavo Nurmi Marathon 2018

Informed consent signed

You may not qualify if:

No informed consent
existing coronary artery disease

Contact the study team to confirm eligibility.

Primary Completion

December 1, 2022

Actual (reported)

Study Completion

December 1, 2022

Actual (reported)

Last Updated

May 8, 2024

Record last verified: 2024-05

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT03738631
Data provider: ClinicalTrials.gov
Source updated: 2024-05-08
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:38:02 UTC

Locations

FI(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (2)

Study Arms (2)

Under 35 years

Over 44 years

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations